Total Payments
$102,657
2024 Payments
$18,056
Companies
80
Transactions
464
Medicare Patients
4,985
Medicare Billing
$594,984
Payment Breakdown by Category
Consulting$43,429 (42.3%)
Other$43,287 (42.2%)
Food & Beverage$10,283 (10.0%)
Travel$5,417 (5.3%)
Education$242.15 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $43,429 | 23 | 42.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,367 | 13 | 36.4% |
| Food and Beverage | $10,283 | 390 | 10.0% |
| Honoraria | $5,920 | 6 | 5.8% |
| Travel and Lodging | $5,417 | 20 | 5.3% |
| Education | $242.15 | 11 | 0.2% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$102,657
463 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $35,403 | 37 | $0 (2024) |
| EMD Serono, Inc. | $7,550 | 16 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $7,190 | 14 | $0 (2023) |
| Deciphera Pharmaceuticals Inc. | $5,740 | 9 | $0 (2022) |
| Rigel Pharmaceuticals, Inc. | $5,411 | 11 | $0 (2024) |
| Eisai Inc. | $5,341 | 38 | $0 (2024) |
| PFIZER INC. | $4,141 | 14 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $3,504 | 15 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $3,382 | 4 | $0 (2024) |
| Seagen Inc. | $3,108 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,056 | 105 | EMD Serono, Inc. ($7,416) |
| 2023 | $5,843 | 72 | TAIHO ONCOLOGY, INC. ($2,237) |
| 2022 | $30,821 | 62 | Ipsen Biopharmaceuticals, Inc ($24,446) |
| 2021 | $15,985 | 72 | Ipsen Biopharmaceuticals, Inc ($7,135) |
| 2020 | $5,612 | 51 | Seagen Inc. ($1,671) |
| 2019 | $14,197 | 51 | Bayer HealthCare Pharmaceuticals Inc. ($6,246) |
| 2018 | $9,049 | 33 | Eisai Inc. ($4,828) |
| 2017 | $3,096 | 18 | Heron Therapeutics, Inc. ($1,696) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Oncology | ||||||
| 12/17/2024 | JAZZ PHARMACEUTICALS INC. | ZIIHERA (Drug) | Food and Beverage | In-kind items and services | $122.13 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $804.75 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $30.99 | General |
| 11/19/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: Oncology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Lilly USA, LLC | JAYPIRCA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: CELLT | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.88 | General |
| Category: Oncology | ||||||
| 10/10/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/08/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: Oncology | ||||||
| 09/25/2024 | JAZZ PHARMACEUTICALS INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,204.00 | General |
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.04 | General |
| 09/23/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Oncology | ||||||
| 09/17/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| Category: Oncology | ||||||
| 09/09/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Oncology | ||||||
| 08/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 1,300 | 22,986 | $915,794 | $179,397 |
| 2022 | 37 | 1,355 | 21,481 | $774,481 | $153,581 |
| 2021 | 30 | 1,225 | 45,674 | $1.0M | $144,084 |
| 2020 | 25 | 1,105 | 21,418 | $501,516 | $117,922 |
Total Patients
4,985
Total Services
111,559
Medicare Billing
$594,984
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 425 | $165,750 | $38,448 | 23.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 44 | 291 | $122,511 | $27,063 | 22.1% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 21 | 26 | $115,622 | $20,049 | 17.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 61 | 101 | $74,567 | $16,148 | 21.7% |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 2023 | 27 | 122 | $25,620 | $8,634 | 33.7% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 14 | 5,980 | $35,880 | $8,239 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 61 | $33,550 | $7,639 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 119 | $32,963 | $7,394 | 22.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 190 | 799 | $23,171 | $6,073 | 26.2% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 22 | 102 | $20,910 | $4,718 | 22.6% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 64 | 104 | $38,610 | $4,532 | 11.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $17,498 | $4,190 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $14,761 | $3,269 | 22.1% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 33 | 143 | $14,729 | $2,985 | 20.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $9,744 | $2,352 | 24.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 30 | 171 | $11,286 | $1,909 | 16.9% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 46 | $8,280 | $1,814 | 21.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 25 | $5,350 | $1,523 | 28.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 94 | 181 | $1,629 | $1,514 | 92.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 32 | $6,656 | $1,502 | 22.6% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 15 | 18 | $27,594 | $1,458 | 5.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 15 | 66 | $10,824 | $1,357 | 12.5% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 12 | 20 | $6,680 | $1,353 | 20.2% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 29 | 1,540 | $63,140 | $1,272 | 2.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 70 | 10,236 | $10,236 | $1,160 | 11.3% |
About Dr. Sameh Mikhail, M.D
Dr. Sameh Mikhail, M.D is a Hematology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447455720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameh Mikhail, M.D has received a total of $102,657 in payments from pharmaceutical and medical device companies, with $18,056 received in 2024. These payments were reported across 464 transactions from 80 companies. The most common payment nature is "Consulting Fee" ($43,429).
As a Medicare-enrolled provider, Mikhail has provided services to 4,985 Medicare beneficiaries, totaling 111,559 services with total Medicare billing of $594,984. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Columbus, OH
- Active Since 06/18/2007
- Last Updated 01/12/2023
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1447455720
Products in Payments
- ONIVYDE (Drug) $27,831
- SOMATULINE DEPOT (Drug) $7,432
- Nexavar (Drug) $6,246
- QINLOCK (Drug) $5,740
- Tavalisse (Drug) $5,356
- Lenvima (Drug) $5,341
- XALKORI (Drug) $3,825
- LONSURF (Drug) $3,385
- Enhertu (Drug) $1,833
- SUSTOL (Drug) $1,709
- ADCETRIS (Biological) $1,666
- TEVIMBRA (Drug) $1,625
- Vistogard (Drug) $1,500
- Vonjo (Drug) $1,476
- TAZVERIK (Drug) $1,317
- ENHERTU (Drug) $1,110
- CYRAMZA (Drug) $971.04
- Stivarga (Drug) $913.06
- BRUKINSA (Drug) $815.53
- KEYTRUDA (Biological) $376.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Columbus
Uma Borate, M.d, M.D
Hematology — Payments: $320,191
Hematology $320,191
Kami Maddocks, Md, MD
Hematology — Payments: $219,606
Hematology $219,606
Yvonne Efebera, Md, MD
Hematology — Payments: $194,251
Hematology $194,251
Amy Dunn, Md, MD
Hematology — Payments: $179,229
Hematology $179,229
Naresh Bumma, M.d, M.D
Hematology — Payments: $122,420
Hematology $122,420
Dr. Kerry Rogers, Md, MD
Hematology — Payments: $82,508
Hematology $82,508